Effect of Food on the Pharmacokinetics of Once-Daily Cyclobenzaprine Extended-Release 30 mg: A Randomized, Open-Label, Crossover, Single-Centre Study

By Darwish Mona  

Clinical Drug Investigation, Vol. 29, Iss. 3, 2009-02 ,pp. : 145-152

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of a Fixed-Dose Combination of Atorvastatin and Metformin Extended Release versus Concurrent Administration of Individual Formulations: A Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single-Dose, Crossover, Bioequivalence Study

By Kandhwal Kirti  

Clinical Drug Investigation, Vol. 31, Iss. 12, 2011-12 ,pp. : 853-863

Adis International

Access to resources Recommend Favorite

Single-Dose Pharmacokinetics of Once-Daily Cyclobenzaprine Extended Release 30 mg versus Cyclobenzaprine Immediate Release 10 mg Three Times Daily in Healthy Young Adults: A Randomized, Open-Label, Two-Period Crossover, Single-Centre Study

By Darwish Mona   Hellriegel Edward T.   Xie Fang  

Clinical Drug Investigation, Vol. 28, Iss. 12, 2008-01 ,pp. : 793-801

Adis International

Access to resources Recommend Favorite

Comparison of the Single-Dose Pharmacokinetics of Once-Daily Cyclobenzaprine Extended-Release 30 mg and Cyclobenzaprine Immediate-Release 10 mg Three Times Daily in the Elderly: A Randomized, Open-Label, Crossover Study

By Darwish Mona  

Drugs & Aging, Vol. 26, Iss. 2, 2009-01 ,pp. : 95-101

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Venlafaxine Extended Release 75 mg and Desvenlafaxine 50 mg in Healthy CYP2D6 Extensive and Poor Metabolizers: A Randomized, Open-Label, Two-Period, Parallel-Group, Crossover Study

By Nichols Alice I.  

Clinical Drug Investigation, Vol. 31, Iss. 3, 2011-03 ,pp. : 155-167

Adis International

Access to resources Recommend Favorite